Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.

NCT00216008 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

42

Enrollment

OTHER

Sponsor class

Stopped IRB Closure

Conditions

Esophageal Adenocarcinomas
Adenocarcinomas of the Gastroesophageal Junction

Interventions

DRUG: docetaxel
DRUG: cisplatin
PROCEDURE: radiation
PROCEDURE: surgery

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]